Skip to content
  • About
  • Contact
  • Contribute
  • Book
  • Careers
  • Podcast
  • Recommended
  • Speaking
  • All
  • Physician
  • Practice
  • Policy
  • Finance
  • Conditions
  • .edu
  • Patient
  • Meds
  • Tech
  • Social
  • Video
    • All
    • Physician
    • Practice
    • Policy
    • Finance
    • Conditions
    • .edu
    • Patient
    • Meds
    • Tech
    • Social
    • Video
    • About
    • Contact
    • Contribute
    • Book
    • Careers
    • Podcast
    • Recommended
    • Speaking

Are we underestimating the danger of prions and prion based diseases?

Robert Trent
Conditions
January 27, 2021
Share
Tweet
Share

Assessment without definition: a flat tire on the road of progress

Even though we have known about prions for decades, very little progress has been made in defining what a prion is vs. what a prion is not, how they get into the brain, and how prion diseases are different from other neurodegenerative diseases. Phenomenologically these definitions can vary widely. To some, a prion causes a deadly, untestable (in clinical practice), and incurable neurodegenerative disease. To others, a prion is what forms long-term memories. To others still, a prion is what causes anti-fungal resistance and allows life forms to evolve in new environments.

This wide range of variation in how we define what a prion is vs. what a prion does not leads to unproductive conversations among professionals working in relevant fields of study. Subsequently, unproductive conversations lead to delays in scientific progress. I have personally witnessed very well educated individuals talking past each other solely because of poorly established definitions. I believe that we can, and absolutely should, do better in guiding our discussions and research on prions and prion based diseases by establishing a well understood standardized definition. I also believe that this poor definition is putting health care workers and researchers alike at risk for unnecessary exposure.

Without a working definition of what a prion is and what prion based diseases are, we are left unable to assess the risk associated with them. There is evidence that Alzheimer’s is an infectious prion disease. Descriptively, Alzheimer’s has many similarities with Parkinson’s, schizophrenia, and many other diseases.  Since we are mostly using phenomenological definitions of what constitutes a prion, Alzheimer’s and other prion diseases end up becoming undifferentiable, and therefore we cannot say with certainty that Alzheimer’s is not a prion disease.

When we look at the alarmingly high rates of hepatitis C among the elderly that was caused by improper instrument sterilization and not by the drug friendly promiscuous lifestyle of the 60s. One has to consider if the current Alzheimer epidemic has been caused by prion-based diseases acquired from poor surgical sterilization in the 50s. The impact of the Alzheimer’s epidemic has been incredibly severe and more work needs to be done in order to fully understand cause, effect, and then prevention.

Proactive not reactive

Science does not make outright claims that events will either happen or not, but merely ascribes the probability of an event happening based on the initial conditions. Since everything that makes up Cells, organs, and organisms is exponentially dependent on initial conditions, we can’t make definite predictions on large scale events.

This leads me to my next point: I am advocating that we invoke a proactive, rather than reactive stance that Alzheimer’s and other neurodegenerative diseases are infectious prion-based diseases.

This implies that when handling nervous tissue, we should act under the assumption that the nervous tissue contains hitherto unknown infectious prions, even if there are no indicators that this is the case. Nervous tissue is often handled at biosafety level 2 (BSL2). However, most infectious prions (that are known of) are assigned to a biosafety level of 3 (BSL3). When I worked in diagnostics, no testing was ever done on nervous tissue to see if prions were present or not. Given the exceedingly long time it takes for prion-based diseases to cross a threshold of pathology whereby the infection becomes detectable to a clinician, we cannot rely on epidemiological data to ensure health care workers’ safety, we must be proactive and precautious in our actions and not reactive.

Pascal’s wager and gun safety

If you have ever taken a hunter’s education course on gun safety, you will have witnessed an example of Pascal’s wager being applied. The first rule of gun safety is to assume that any gun is loaded and can go off at any time. When carrying a gun, it should always be pointed at the ground and away from anything that might be damaged or injured should the gun go off and fire. These rules are applied and carried out by any responsible gun owner even when they know that the gun is not loaded and that the safety is on. Despite the fact that there is virtually no possible way that the gun could fire a live round, the responsible course of action is to act as if the gun could go off at any time. This paranoid course of action is utilized because the severity of the outcome whereby the gun fires and kills someone is so large that even if the odds are small, the outcome is significant, should the unlikely event occur. This is exactly the approach we should be taking towards handling nervous tissue, prions, and prion based diseases. Pathologists, cytotechnologists, medical school anatomy labs, and etc., should be operating under BSL3 precautions when handling nervous tissue, not BSL2.

Robert Trent is a graduate student.

Image credit: Shutterstock.com

Prev

A surgeon left his own son's funeral to take care of your child

January 27, 2021 Kevin 7
…
Next

14 tips when negotiating a physician job

January 27, 2021 Kevin 0
…

ADVERTISEMENT

Tagged as: Neurology

Post navigation

< Previous Post
A surgeon left his own son's funeral to take care of your child
Next Post >
14 tips when negotiating a physician job

ADVERTISEMENT

ADVERTISEMENT

ADVERTISEMENT

More by Robert Trent

  • Biologics are not small molecules: the case for pre-allergy testing in an era of immune-based therapies

    Robert Trent
  • Does the FDA approval of aducanumab mark the return of science-based medicine?

    Robert Trent
  • Getting a second opinion can save lives. It is time we make Miranda rights for patients.

    Robert Trent

Related Posts

  • The expanding role of specialists in value-based care

    Martin Lustick, MD
  • Lessons from the meeting of different value-based concepts

    Joshua Liao, MD
  • Behavioral health providers face challenges in value-based care

    Martin Lustick, MD
  • In crisis, danger and opportunity are present

    Casey P. Schukow, DO
  • Considering the recent setbacks of evidence-based medicine

    Kenneth Lin, MD
  • Market-based approaches solving the opioid epidemic

    Julie Craig, MD

More in Conditions

  • Does silence as a faculty retention strategy in academic medicine and health sciences work?

    Sylk Sotto, EdD, MPS, MBA
  • Why personal responsibility is not enough in the fight against nicotine addiction

    Travis Douglass, MD
  • AI in mental health: a new frontier for therapy and support

    Tim Rubin, PsyD
  • What prostate cancer taught this physician about being a patient

    Francisco M. Torres, MD
  • Why ADHD in women is finally getting the attention it deserves

    Arti Lal, MD
  • Why ruling out sepsis in emergency departments can be lifesaving

    Claude M. D'Antonio, Jr., MD
  • Most Popular

  • Past Week

    • What’s driving medical students away from primary care?

      ​​Vineeth Amba, MPH, Archita Goyal, and Wayne Altman, MD | Education
    • Make cognitive testing as routine as a blood pressure check

      Joshua Baker and James Jackson, PsyD | Conditions
    • The hidden cost of delaying back surgery

      Gbolahan Okubadejo, MD | Conditions
    • The dreaded question: Do you have boys or girls?

      Pamela Adelstein, MD | Physician
    • Rethinking patient payments: Why billing is the new frontline of patient care [PODCAST]

      The Podcast by KevinMD | Podcast
    • The broken health care system doesn’t have to break you

      Jessie Mahoney, MD | Physician
  • Past 6 Months

    • What’s driving medical students away from primary care?

      ​​Vineeth Amba, MPH, Archita Goyal, and Wayne Altman, MD | Education
    • What happened to real care in health care?

      Christopher H. Foster, PhD, MPA | Policy
    • Internal Medicine 2025: inspiration at the annual meeting

      American College of Physicians | Physician
    • The hidden bias in how we treat chronic pain

      Richard A. Lawhern, PhD | Meds
    • A faster path to becoming a doctor is possible—here’s how

      Ankit Jain | Education
    • Residency as rehearsal: the new pediatric hospitalist fellowship requirement scam

      Anonymous | Physician
  • Recent Posts

    • Rediscovering the soul of medicine in the quiet of a Sunday morning

      Syed Ahmad Moosa, MD | Physician
    • An introduction to occupational and environmental medicine [PODCAST]

      The Podcast by KevinMD | Podcast
    • Does silence as a faculty retention strategy in academic medicine and health sciences work?

      Sylk Sotto, EdD, MPS, MBA | Conditions
    • Why personal responsibility is not enough in the fight against nicotine addiction

      Travis Douglass, MD | Conditions
    • How dismantling DEI endangers the future of medical care

      Shashank Madhu and Christian Tallo | Education
    • Alzheimer’s and the family: Opening the conversation with children [PODCAST]

      The Podcast by KevinMD | Podcast

Subscribe to KevinMD and never miss a story!

Get free updates delivered free to your inbox.


Find jobs at
Careers by KevinMD.com

Search thousands of physician, PA, NP, and CRNA jobs now.

Learn more

Leave a Comment

Founded in 2004 by Kevin Pho, MD, KevinMD.com is the web’s leading platform where physicians, advanced practitioners, nurses, medical students, and patients share their insight and tell their stories.

Social

  • Like on Facebook
  • Follow on Twitter
  • Connect on Linkedin
  • Subscribe on Youtube
  • Instagram

ADVERTISEMENT

ADVERTISEMENT

ADVERTISEMENT

ADVERTISEMENT

  • Most Popular

  • Past Week

    • What’s driving medical students away from primary care?

      ​​Vineeth Amba, MPH, Archita Goyal, and Wayne Altman, MD | Education
    • Make cognitive testing as routine as a blood pressure check

      Joshua Baker and James Jackson, PsyD | Conditions
    • The hidden cost of delaying back surgery

      Gbolahan Okubadejo, MD | Conditions
    • The dreaded question: Do you have boys or girls?

      Pamela Adelstein, MD | Physician
    • Rethinking patient payments: Why billing is the new frontline of patient care [PODCAST]

      The Podcast by KevinMD | Podcast
    • The broken health care system doesn’t have to break you

      Jessie Mahoney, MD | Physician
  • Past 6 Months

    • What’s driving medical students away from primary care?

      ​​Vineeth Amba, MPH, Archita Goyal, and Wayne Altman, MD | Education
    • What happened to real care in health care?

      Christopher H. Foster, PhD, MPA | Policy
    • Internal Medicine 2025: inspiration at the annual meeting

      American College of Physicians | Physician
    • The hidden bias in how we treat chronic pain

      Richard A. Lawhern, PhD | Meds
    • A faster path to becoming a doctor is possible—here’s how

      Ankit Jain | Education
    • Residency as rehearsal: the new pediatric hospitalist fellowship requirement scam

      Anonymous | Physician
  • Recent Posts

    • Rediscovering the soul of medicine in the quiet of a Sunday morning

      Syed Ahmad Moosa, MD | Physician
    • An introduction to occupational and environmental medicine [PODCAST]

      The Podcast by KevinMD | Podcast
    • Does silence as a faculty retention strategy in academic medicine and health sciences work?

      Sylk Sotto, EdD, MPS, MBA | Conditions
    • Why personal responsibility is not enough in the fight against nicotine addiction

      Travis Douglass, MD | Conditions
    • How dismantling DEI endangers the future of medical care

      Shashank Madhu and Christian Tallo | Education
    • Alzheimer’s and the family: Opening the conversation with children [PODCAST]

      The Podcast by KevinMD | Podcast

MedPage Today Professional

An Everyday Health Property Medpage Today
  • Terms of Use | Disclaimer
  • Privacy Policy
  • DMCA Policy
All Content © KevinMD, LLC
Site by Outthink Group

Leave a Comment

Comments are moderated before they are published. Please read the comment policy.

Loading Comments...